- Patient engagement is a continuous process that improves recruitment, retention, and data validity.
- Active involvement during the trial helps mitigate the high industry dropout rate of 40%.
- Post-trial engagement through result sharing builds transparency and provides valuable long-term safety data.
- Digital solutions like the Virtual Waiting Room significantly outperform industry averages for patient participation and kit returns.
Patient engagement before, during, and after a trial
Patient engagement plays a pivotal role at the start of any clinical trial. Active involvement of patients at this stage helps researchers gain valuable insights into the design and execution of the study. By incorporating the perspectives and preferences of patients, researchers can ensure that the trial's objectives align with the real-world needs of the patient population. Engaging patients before clinical trials also facilitates the identification of potential barriers to participation, thus enhancing recruitment and retention rates. By fostering open communication and collaboration, researchers can create a more patient-centric trial environment, leading to improved study outcomes and greater patient satisfaction.
With up to 40% of patients dropping out of trials, patient retention is a significant challenge in clinical research. When patients are informed and supported throughout a trial, they are more likely to adhere to the study protocol, report symptoms accurately, and remain enrolled through completion. Sustained engagement during the trial directly affects protocol adherence, screen failure rates, and the completeness of data collected at each timepoint. Participants who remain consistently informed about the study process and their own progress are less likely to withdraw, and more likely to provide usable data at each collection point—outcomes that compound in significance across longer or more complex studies.
Even when a trial is over, the work of patient engagement is far from complete. In the post-trial phase, it becomes crucial to share the study findings with the participating patients. Sharing results with participants after a study closes maintains the integrity of the sponsor-participant relationship and creates the conditions for future engagement—whether for recontact, follow-on studies, or real-world evidence collection. When participants understand the outcomes of a study they contributed to, their willingness to engage in future research—including recontact for extension studies or registry participation—is meaningfully higher. Moreover, continued engagement allows researchers to collect long-term data on the treatment's effectiveness and safety, aiding in the assessment of real-world outcomes. Involving patients in the interpretation and application of trial results is a patient-centered approach that ensures treatments align with patients' needs and preferences.
Maintaining engagement between site visits and study phases
The Virtual Waiting Room addresses these gaps by creating a structured digital environment through which sponsors can maintain consistent, relevant communication with patients between site visits and across study phases. The Virtual Waiting room creates a digital environment through which those running studies can deliver tailored content to patients throughout a study, including between site visits and across study phases, without requiring separate tooling or manual outreach for each touchpoint. – including between site visits and study phases. Patients receive communications that are relevant to their stage in the study, such as testing reminders, educational material, and results summaries, which keeps them informed and reduces the likelihood of disengagement. And the results speak for themselves: over 80% of patients return their DNA test kits, less than 1% of patients withdraw from studies that use the Virtual Waiting Room, and 65% of study-related emails are read by Sano patients, significantly higher than the 21% industry average. The platform also maintains structured contact with individuals who do not currently meet eligibility criteria, preserving the connection for future recontact as criteria change, new assets progress through the pipeline, or additional studies open in the same therapy area.
Conclusion
Patient engagement is crucial for successful clinical trials. It begins before the trial, ensuring alignment with patient needs and improving recruitment. During the trial, engaged patients contribute to accurate data collection and better outcomes. After the trial, engaging patients in result dissemination fosters transparency and empowers informed decision-making. Tools like the Virtual Waiting Room are pushing the boundaries of patient engagement, promising more efficient and effective clinical trials in the future. By embracing patient engagement throughout the trial process, researchers can enhance enrollment, retention, and overall success, ultimately advancing healthcare for the benefit of patients worldwide.